Repligen (RGEN) 2025 Earnings: Outlook & Takeaways
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Allocating to a wide market index fund for retirement aims to spread risk across the market, supporting steady growth while keeping fees reasonable.
28,235 articlesAs biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
In 2026, investors face a choice between a global industrial leader and a defense-focused specialist. This guide brea...
As the S&P 500 retreats, two growth-focused ETFs show resilience. This report breaks down why FELG and QQQ are defyin...
OpenAI reportedly considers delaying its IPO, placing AI stocks in the spotlight. This guide breaks down the potentia...
As the Dow breaks above 50,000 in early 2026, investors revisit the ghost 36,000 milestone and debate whether old bet...
Warren Buffett's looming Berkshire Hathaway exit plans could reshape both philanthropy and investing. This analysis e...
Investors are shifting from traditional savings toward monthly dividend ETFs offering higher yields. This report brea...
Institutional buyers are flocking to STRC, Strategy’s variable-rate perpetual preferred stock, driving an 11% yield a...
Investors chase the next big AI champion. This piece breaks down how a single AI stock could grow into a trillion-dol...
A sharp move in a gold royalty stock can trigger questions for both traders and long-term investors. This article bre...
Long-term holders in NVDA, AMD, and LLY are posting outsized gains as AI and GLP-1 drug momentum persists. Traders wh...
The SpaceX IPO dominates chatter, but you don’t have to wait to gain space exposure. Here are three space stocks with...